Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (...

Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (HRNB)  PR Newswire

Swissmedic issues warning against falsified and misleading “GLP-1” weight loss products - Swissmedic

Swissmedic issues warning against falsified and misleading “GLP-1” weight loss products  Swissmedic

Euro Roundup: Swissmedic pilots fast-track procedure to accelerate clinical trial authorizations ...

Euro Roundup: Swissmedic pilots fast-track procedure to accelerate clinical trial authorizations  Regulatory Affairs Professionals Society | RAPS

Swissmedic approves Novartis’ malaria medicine for babies - Pharmaceutical Technology

Swissmedic approves Novartis’ malaria medicine for babies  Pharmaceutical Technology

Swissmedic approves first malaria treatment for infants - drugdiscoverytrends.com

Swissmedic approves first malaria treatment for infants  drugdiscoverytrends.com

KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY - Busin...

KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY  Business Wire

Swissmedic plans job cuts amid mounting financial pressures - SWI swissinfo.ch

Swissmedic plans job cuts amid mounting financial pressures  SWI swissinfo.ch

Agency for Therapeutic Products: Swissmedic to cut around 45 full-time positions within two years...

Agency for Therapeutic Products: Swissmedic to cut around 45 full-time positions within two years | blue News  blue News

Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein...

Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH)  the-scientist.com

Regulatory Challenges: Is a Surrogate End Point Instead of Overall Survival Enough for Regulatory...

Regulatory Challenges: Is a Surrogate End Point Instead of Overall Survival Enough for Regulatory Approval of (Neo)Adjuvant Cancer Treatment? The Swissmedic Perspective  ASCO Publications

Swissmedic reinforces Switzerland’s role in global regulatory collaboration and advanced therapeu...

Swissmedic reinforces Switzerland’s role in global regulatory collaboration and advanced therapeutics  ggba.swiss

Swissmedic reorg adds new focus on medical device market surveillance - AgencyIQ by POLITICO

Swissmedic reorg adds new focus on medical device market surveillance  AgencyIQ by POLITICO

Speedy Switzerland - Visible - Swissmedic

Speedy Switzerland - Visible  Swissmedic

Swissmedic updates guidances on API, fast-track pathway, and more - Regulatory Affairs Profession...

Swissmedic updates guidances on API, fast-track pathway, and more  Regulatory Affairs Professionals Society | RAPS

"Significant health risk": Swissmedic warns of dangerous fake weight loss syringes | blue News - ...

"Significant health risk": Swissmedic warns of dangerous fake weight loss syringes | blue News  blue News

Clinical studies - Visible - Swissmedic

Clinical studies - Visible  Swissmedic

Euro Roundup: Swissdamed registration module goes live ahead of mandatory use - Regulatory Affair...

Euro Roundup: Swissdamed registration module goes live ahead of mandatory use  Regulatory Affairs Professionals Society | RAPS

"Swissmedic 4.0" digital initiative concludes - Swissmedic

"Swissmedic 4.0" digital initiative concludes  Swissmedic

Swissmedic updates adverse event reporting requirements for 2024 - Regulatory Affairs Professiona...

Swissmedic updates adverse event reporting requirements for 2024  Regulatory Affairs Professionals Society | RAPS

Swissmedic issues warning about the illegal medicinal product "Lemon Bottle" lipolysis solution -...

Swissmedic issues warning about the illegal medicinal product "Lemon Bottle" lipolysis solution  Swissmedic

Swissmedic survey finds drug approval timelines slower than EMA, FDA - Regulatory Affairs Profess...

Swissmedic survey finds drug approval timelines slower than EMA, FDA  Regulatory Affairs Professionals Society | RAPS

Swissmedic moves more slowly in reviewing medicines - The Pharma Letter

Swissmedic moves more slowly in reviewing medicines  The Pharma Letter

Collaborative training of regulators as an approach for strengthening regulatory systems in LMICs...

Collaborative training of regulators as an approach for strengthening regulatory systems in LMICs: experiences of the WHO and Swissmedic  Frontiers

Kamada’s Glassia receives marketing approval from Swissmedic - Pharmaceutical Technology

Kamada’s Glassia receives marketing approval from Swissmedic  Pharmaceutical Technology

CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the...

CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy  PR Newswire

Study: FDA more likely to approve drugs for broader populations than EMA, Swissmedic - Regulatory...

Study: FDA more likely to approve drugs for broader populations than EMA, Swissmedic  Regulatory Affairs Professionals Society | RAPS

Pfizer applies to Swissmedic for authorisation of another COVID-19 vaccine - Reuters

Pfizer applies to Swissmedic for authorisation of another COVID-19 vaccine  Reuters

Swissmedic Grants Good Manufacturing Practice Multi-Product License to Biogen Biologics Facility ...

Swissmedic Grants Good Manufacturing Practice Multi-Product License to Biogen Biologics Facility in Solothurn, Switzerland  Biogen

Swissmedic authorizes CSL's Hemgenix for hemophilia B - The Pharma Letter

Swissmedic authorizes CSL's Hemgenix for hemophilia B  The Pharma Letter

First malaria treatment for newborn babies approved for use - The Washington Post

First malaria treatment for newborn babies approved for use  The Washington Post

No indication of risk due to COVID-19 booster shot bubbles -Swissmedic - Reuters

No indication of risk due to COVID-19 booster shot bubbles -Swissmedic  Reuters

Product groups without an intended medical purpose - Swissmedic

Product groups without an intended medical purpose  Swissmedic

Swiss regulator warns against dangerous weight loss products - SWI swissinfo.ch

Swiss regulator warns against dangerous weight loss products  SWI swissinfo.ch

“Revolving doors” with the pharmaceutical industry: a major source of influence on Swiss regulato...

“Revolving doors” with the pharmaceutical industry: a major source of influence on Swiss regulatory bodies?  Public Eye

Swiss medicines regulator responds to Trump’s paracetamol claim - SWI swissinfo.ch

Swiss medicines regulator responds to Trump’s paracetamol claim  SWI swissinfo.ch

Novartis given green light for infant anti-malaria drug - SWI swissinfo.ch

Novartis given green light for infant anti-malaria drug  SWI swissinfo.ch

CHUV introduces Switzerland's first gut-balancing medication - ggba.swiss

CHUV introduces Switzerland's first gut-balancing medication  ggba.swiss

Illegal imports 2021: Swissmedic seizes significantly more packages than in 2020 - Swissmedic

Illegal imports 2021: Swissmedic seizes significantly more packages than in 2020  Swissmedic

VMD and Swissmedic agree collaboration on veterinary medicinal products - GOV.UK

VMD and Swissmedic agree collaboration on veterinary medicinal products  GOV.UK

Committed to the next generation - Swissmedic

Committed to the next generation  Swissmedic

What does the name Swissmedic mean to you? - Swissmedic

What does the name Swissmedic mean to you?  Swissmedic

Meet René: The IDF’s First Ever Swiss-Bedouin Medic - idf.il

Meet René: The IDF’s First Ever Swiss-Bedouin Medic  idf.il

Swiss regulator and media clash over weight-loss drugs - SWI swissinfo.ch

Swiss regulator and media clash over weight-loss drugs  SWI swissinfo.ch

The handbook of medicinal product quality - Swissmedic

The handbook of medicinal product quality  Swissmedic

Interview with Swissmedic Agency Council Chair Lukas Bruhin - Swissmedic

Interview with Swissmedic Agency Council Chair Lukas Bruhin  Swissmedic

Swissmedic authorises new drug for respiratory disease - SWI swissinfo.ch

Swissmedic authorises new drug for respiratory disease  SWI swissinfo.ch

Swissmedic approves Novartis' new heart failure medicine Entresto(TM) - Novartis

Swissmedic approves Novartis' new heart failure medicine Entresto(TM)  Novartis

Interview with Raimund Bruhin, Executive Director of Swissmedic - Swissmedic

Interview with Raimund Bruhin, Executive Director of Swissmedic  Swissmedic

Santhera Receives Swissmedic Approval of AGAMREE® (Vamorolone) for the Treatment of Duchenne Musc...

Santhera Receives Swissmedic Approval of AGAMREE® (Vamorolone) for the Treatment of Duchenne Muscular Dystrophy  The Manila Times

Johnson & Johnson Covid vaccine approved for use in Switzerland - SWI swissinfo.ch

Johnson & Johnson Covid vaccine approved for use in Switzerland  SWI swissinfo.ch

Illegally imported medicinal products: underestimated risks! - Swissmedic

Illegally imported medicinal products: underestimated risks!  Swissmedic

Personalisierter Hirnstimulator bei Swissmedic registriert - Medinside

Personalisierter Hirnstimulator bei Swissmedic registriert  Medinside

Swissmedic approves first bivalent Covid-19 booster - arynews.tv

Swissmedic approves first bivalent Covid-19 booster  arynews.tv

Switzerland Clears First Malaria Medicine for Small Babies - Adda247

Switzerland Clears First Malaria Medicine for Small Babies  Adda247